These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30222202)

  • 1. Intestinal barrier integrity in patients with plaque psoriasis.
    Sikora M; Chrabąszcz M; Maciejewski C; Zaremba M; Waśkiel A; Olszewska M; Rudnicka L
    J Dermatol; 2018 Dec; 45(12):1468-1470. PubMed ID: 30222202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Claudin- 3 as a biomarker of gut-skin axis integrity in patients with psoriasis.
    Mahran A; Hosni AM; Farag NG; Elkhawaga AA; Mageed AAA
    Arch Dermatol Res; 2024 Jul; 316(7):476. PubMed ID: 39023797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Claudin-3 - a new intestinal integrity marker in patients with psoriasis: association with disease severity.
    Sikora M; Chrabąszcz M; Waśkiel-Burnat A; Rakowska A; Olszewska M; Rudnicka L
    J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1907-1912. PubMed ID: 31120609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary Gluten-Induced Gut Dysbiosis Is Accompanied by Selective Upregulation of microRNAs with Intestinal Tight Junction and Bacteria-Binding Motifs in Rhesus Macaque Model of Celiac Disease.
    Mohan M; Chow CT; Ryan CN; Chan LS; Dufour J; Aye PP; Blanchard J; Moehs CP; Sestak K
    Nutrients; 2016 Oct; 8(11):. PubMed ID: 27801835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis.
    Ciccia F; Guggino G; Rizzo A; Alessandro R; Luchetti MM; Milling S; Saieva L; Cypers H; Stampone T; Di Benedetto P; Gabrielli A; Fasano A; Elewaut D; Triolo G
    Ann Rheum Dis; 2017 Jun; 76(6):1123-1132. PubMed ID: 28069576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota dysbiosis in a cohort of patients with psoriasis.
    Hidalgo-Cantabrana C; Gómez J; Delgado S; Requena-López S; Queiro-Silva R; Margolles A; Coto E; Sánchez B; Coto-Segura P
    Br J Dermatol; 2019 Dec; 181(6):1287-1295. PubMed ID: 30920647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal Barrier Breakdown and Mucosal Microbiota Disturbance in Neuromyelitis Optical Spectrum Disorders.
    Cui C; Tan S; Tao L; Gong J; Chang Y; Wang Y; Fan P; He D; Ruan Y; Qiu W
    Front Immunol; 2020; 11():2101. PubMed ID: 32983166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human small intestine is capable of restoring barrier function after short ischemic periods.
    Schellekens DH; Hundscheid IH; Leenarts CA; Grootjans J; Lenaerts K; Buurman WA; Dejong CH; Derikx JP
    World J Gastroenterol; 2017 Dec; 23(48):8452-8464. PubMed ID: 29358855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Implications of Intestinal Barrier Damage in Psoriasis.
    Sikora M; Stec A; Chrabaszcz M; Giebultowicz J; Samborowska E; Jazwiec R; Dadlez M; Olszewska M; Rudnicka L
    J Inflamm Res; 2021; 14():237-243. PubMed ID: 33542642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis.
    Sikora M; Stec A; Chrabaszcz M; Waskiel-Burnat A; Zaremba M; Olszewska M; Rudnicka L
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31336842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting the Zonulin Mouse Model to Establish the Role of Primary Impaired Gut Barrier Function on Microbiota Composition and Immune Profiles.
    Miranda-Ribera A; Ennamorati M; Serena G; Cetinbas M; Lan J; Sadreyev RI; Jain N; Fasano A; Fiorentino M
    Front Immunol; 2019; 10():2233. PubMed ID: 31608059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Claudin-3 is a novel intestinal integrity marker in patients with alopecia areata: Correlation with the disease severity.
    Rafik D; Younis I; Atef R; Eid H
    J Cosmet Dermatol; 2023 Apr; 22(4):1377-1381. PubMed ID: 36606388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure.
    Kim S; Goel R; Kumar A; Qi Y; Lobaton G; Hosaka K; Mohammed M; Handberg EM; Richards EM; Pepine CJ; Raizada MK
    Clin Sci (Lond); 2018 Mar; 132(6):701-718. PubMed ID: 29507058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis.
    Tajik N; Frech M; Schulz O; Schälter F; Lucas S; Azizov V; Dürholz K; Steffen F; Omata Y; Rings A; Bertog M; Rizzo A; Iljazovic A; Basic M; Kleyer A; Culemann S; Krönke G; Luo Y; Überla K; Gaipl US; Frey B; Strowig T; Sarter K; Bischoff SC; Wirtz S; Cañete JD; Ciccia F; Schett G; Zaiss MM
    Nat Commun; 2020 Apr; 11(1):1995. PubMed ID: 32332732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Marrow-Derived Cells Restore Functional Integrity of the Gut Epithelial and Vascular Barriers in a Model of Diabetes and ACE2 Deficiency.
    Duan Y; Prasad R; Feng D; Beli E; Li Calzi S; Longhini ALF; Lamendella R; Floyd JL; Dupont M; Noothi SK; Sreejit G; Athmanathan B; Wright J; Jensen AR; Oudit GY; Markel TA; Nagareddy PR; Obukhov AG; Grant MB
    Circ Res; 2019 Nov; 125(11):969-988. PubMed ID: 31610731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Intestinal Tight Junction Hyperpermeability Alters the Microbiome, Behavior, and Visceromotor Responses.
    Inczefi O; Bacquié V; Olier-Pierre M; Rincel M; Ringot-Destrez B; Ellero-Simatos S; Eutamène H; Bétoulières C; Thomas J; Lainé J; Gros L; Lévêque M; Leonard R; Harkat C; Robbe-Masselot C; Róka R; Mercier-Bonin M; Theodorou V; Darnaudéry M; Turner JR; Ferrier L
    Cell Mol Gastroenterol Hepatol; 2020; 10(1):206-208.e3. PubMed ID: 32147490
    [No Abstract]   [Full Text] [Related]  

  • 17. Gut-liver axis signaling in portal hypertension.
    Simbrunner B; Mandorfer M; Trauner M; Reiberger T
    World J Gastroenterol; 2019 Oct; 25(39):5897-5917. PubMed ID: 31660028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Insight in Loss of Gut Barrier during Major Non-Abdominal Surgery.
    Derikx JP; van Waardenburg DA; Thuijls G; Willigers HM; Koenraads M; van Bijnen AA; Heineman E; Poeze M; Ambergen T; van Ooij A; van Rhijn LW; Buurman WA
    PLoS One; 2008; 3(12):e3954. PubMed ID: 19088854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis.
    Tornai T; Palyu E; Vitalis Z; Tornai I; Tornai D; Antal-Szalmas P; Norman GL; Shums Z; Veres G; Dezsofi A; Par G; Par A; Orosz P; Szalay F; Lakatos PL; Papp M
    World J Gastroenterol; 2017 Aug; 23(29):5412-5421. PubMed ID: 28839442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation.
    Martinez-Medina M; Denizot J; Dreux N; Robin F; Billard E; Bonnet R; Darfeuille-Michaud A; Barnich N
    Gut; 2014 Jan; 63(1):116-24. PubMed ID: 23598352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.